Stem Cell Therapy for Tendon and Ligament Injuries: Beyond PRP
PRP has its limits. For serious tendon and ligament injuries, stem cells are showing results PRP cannot match.
Read More »Cell La Vie Blog
Immunotherapie and Immunology news
Immunotherapie and Immunology news
PRP has its limits. For serious tendon and ligament injuries, stem cells are showing results PRP cannot match.
Read More »A June 2026 study shows that senolytic preconditioning dramatically improves MSC efficacy by removing the SASP factors that suppress tissue repair. Plus: AAT-MSCs reverse diabetes via immune reprogramming, and a phase III MSC trial for meniscal repair reaches completion.
Read More »A 2026 real-world study followed 120 refractory lupus nephritis patients treated with UC-MSCs. Cumulative renal response reached 56.7% at 12 months with low relapse rates and zero severe adverse events. Here’s what clinicians need to know.
Read More »A 36-month clinical trial showed zero adverse events and 57% pain reduction when stem cells were injected into torn rotator cuffs. Here’s what weekend warriors and recreational athletes need to know about MSC therapy for sports injuries.
Read More »Every workout floods your bloodstream with stem cells — your body’s own repair crew. Learn how exercise mobilizes regenerative cells and why it matters for aging and healing.
Read More »The MERIT phase 1 trial published in Cell Reports Medicine shows that intravenous UC-MSC therapy is safe in subacute ischemic stroke, with early NIHSS improvement signals. Here’s what clinicians need to know.
Read More »Reverse Aging at the Cellular Level As we age, our body’s natural stem cell reserves deplete — from robust populations in our 20s to a fraction by age 60. Stem cell anti-aging therapy replenishes these depleted reserves with young, potent mesenchymal stem cells (MSCs) that trigger systemic rejuvenation. How MSCs Reverse Aging Reduce inflammation — […]
Read More »A 2026 Phase I trial shows umbilical cord stem cells delivered directly to the liver can reverse cirrhosis markers.
Read More »A 2026 meta-analysis of 15 RCTs shows MSCs cut acute GvHD incidence by 53% and chronic GvHD by 50%. A biomarker-guided trial identifies which transplant patients benefit most — and a cell-free exosome approach may be next.
Read More »How Much Does Stem Cell Therapy Cost in Thailand? Stem cell therapy in Thailand costs $3,500–$40,000 USD, depending on the treatment type, number of cells used, and protocol complexity. This is 50–70% less than equivalent treatments in the United States, Europe, or Australia — without compromising on quality or safety standards. Cost Breakdown by Treatment […]
Read More »Your body’s stem cell population drops dramatically after 40. Here’s what the science says about why we age — and how regenerative medicine is fighting back.
Read More »